| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_628db03ba4f8948ecd211fb3d46b9ef4 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D239-48 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D239-48 |
| filingDate |
1995-10-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
1997-09-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_bf9d29734aa3e936e708df5596a1f4fa
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4f7eaa37186092f94a7d54e43ca86e9b |
| publicationDate |
1997-09-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-5670508-A |
| titleOfInvention |
2-amino-6-alkyl-5-(4-substituted-1-piperazinyl) pyrimidin-4-ones, the preparation and use thereof |
| abstract |
A series of 2-amino-6-alkyl-5-(4-substituted-1-piperazinyl)pyrimidin-4-ones that have selective cytotoxicity on human CNS tumor cells. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6693099-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/AU-2008334705-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7476680-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7135483-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2006223853-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7652013-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7304053-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2009149466-A1 |
| priorityDate |
1995-10-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |